We accept most major insurance providers and can check your coverage levels for you.
If we are not an appropriate provider for care, we will assist in finding a care provider that can help.
General Inquiry Form
"*" indicates required fields
By submitting this form you agree to the terms of use and privacy policy and give my express written consent for AMFM Healthcare to contact me at the number provided above, even if this number is a wireless number or if I am presently listed on a Do Not Call list.
I understand that I may be contacted by telephone, email, text message or mail regarding my disability benefit case options and that I may be called using automatic dialing equipment. Message and data rates may apply. My consent does not require purchase. Message frequency varies. Text HELP for help. Reply STOP to unsubscribe.
Contact From Admission Representative:
Complete the form to receive a prompt call back from a member of our experienced and compassionate admissions staff. All communication is 100% confidential.
There are a variety of different antidepressant medications that have been proven as effective treatment (in combination with psychological treatment) for depression. Some types of antidepressants are listed here, but inquire with a licensed medical professional or psychiatrist for detailed information on different treatments. Never take psychiatric medication unless it is prescribed to you, and be sure to consult with medical professionals in case of external risk factors.
Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SSNIs)are antidepressant medications that treat different neurotransmitters in order to block the reabsorption of serotonin or norepinephrine, keeping more of the chemicals in the synaptic cleft. Both are effective treatments for depression, but depend upon the individual, and should be approached with medical guidance and professional advice. If you’re currently on medications for any other medical conditions, it’s important to review any over-the-counter medications and their interactions with a medical professional.
General Inquiry Form
"*" indicates required fields
By submitting this form you agree to the terms of use and privacy policy and give my express written consent for AMFM Healthcare to contact me at the number provided above, even if this number is a wireless number or if I am presently listed on a Do Not Call list.
I understand that I may be contacted by telephone, email, text message or mail regarding my disability benefit case options and that I may be called using automatic dialing equipment. Message and data rates may apply. My consent does not require purchase. Message frequency varies. Text HELP for help. Reply STOP to unsubscribe.
Contact From Admission Representative:
Complete the form to receive a prompt call back from a member of our experienced and compassionate admissions staff. All communication is 100% confidential.
AMFM clinical teams offer medication management throughout mental health treatment for your convenience and safety. Trying to navigate the proper dosages, keep track of side effects, monitor organization and timely administration of medications at home can be challenging, dangerous and risky without clinical support or supervision. For those struggling with mental health disorders, clinical support can help take something off your plate–walking through mental health challenges is hard enough alone, so having compassionate clinical care on-hand 24/7.
AMFM Mental Health Treatment offers medication management as a part of the treatment plans, if you are attending an inpatient or outpatient in-person program. In this setting, AMFM staffs clinical professionals to help with medication management in order to ensure that none of your medications are having adverse effects, and to prevent any interactions between medications. As a result, you or your loved one can simply focus on your healing journey. If you’re ready to start your mental health journey, give us a call today.
Yes, most health insurance companies provide some form of coverage for depression treatment. This often includes both inpatient and outpatient care, depending on your symptoms. Coverage generally applies to therapy, counseling, and medication management services. Your plan may have limitations, exclusions, or required authorizations.
We encourage you to verify your coverage with AMFM Mental Health Treatment to understand the full scope of your benefits.
"*" indicates required fields
By submitting this form you agree to the terms of use and privacy policy and give my express written consent for AMFM Healthcare to contact me at the number provided above, even if this number is a wireless number or if I am presently listed on a Do Not Call list.
I understand that I may be contacted by telephone, email, text message or mail regarding my disability benefit case options and that I may be called using automatic dialing equipment. Message and data rates may apply. My consent does not require purchase. Message frequency varies. Text HELP for help. Reply STOP to unsubscribe.
“News Details.” Novo Nordisk, www.novonordisk-us.com/media/news-archive/news-details.html?id=915253. Accessed 14 Apr. 2025.
“Ozempic.” European Medicines Agency (EMA), www.ema.europa.eu/en/medicines/human/EPAR/ozempic. Accessed 14 Apr. 2025.
Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551568/
“Weight Loss: Drugs like Ozempic May Be Linked to Lower Depression Risk.” Medical News Today, MediLexicon International, www.medicalnewstoday.com/articles/weight-loss-drugs-help-lower-depression-and-anxiety-risk. Accessed 14 Apr. 2025.
Neporent, Liz. “Ozempic and Other Weight Loss Drugs Linked to Antidepressant Use.” Psychiatrist.Com, Psychiatrist.com, 26 June 2024, www.psychiatrist.com/news/ozempic-and-other-weight-loss-drugs-linked-to-antidepressant-use/.
Center for Drug Evaluation and Research. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” U.S. Food and Drug Administration, FDA, www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss. Accessed 14 Apr. 2025.
Latif W, Lambrinos KJ, Patel P, et al. Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs) [Updated 2024 Feb 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572151/
“Medication Management Strategy: Intervention | Agency for Healthcare Research and Quality.” | Agency for Healthcare Research and Quality, https://www.ahrq.gov/patient-safety/reports/engage/interventions/medmanage.html. Accessed 3 March 2025.
Corporate Office:
30310 Rancho Viejo Rd.
San Juan Capistrano CA 92675
Fax: 949-421-6977
Email: info@amfmhealthcare.com